Ondansetron, a New Antiemetic Therapy for Oncology
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 25 (sup178) , 55-61
- https://doi.org/10.3109/00365529009093151
Abstract
The nausea and emesis associated with chemotherapy still constitute an important problem in anticancer treatment. The new specific 5-HT3 receptor antagonists appear to be effective against vomiting induced by chemotherapy and radiation. An overview is given of the current theories on the physiology of emesis and the available literature on ondansetron (GR38032F) as an antiemetic.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Identification and Classification of 5-HT1 Receptor SubtypesJournal of Cardiovascular Pharmacology, 1990
- Therapeutic management of nausea and vomitingGeneral Pharmacology: The Vascular System, 1990
- Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several speciesEuropean Journal of Pharmacology, 1989
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Optimum Management of Nausea and Vomiting in Cancer ChemotherapyDrugs, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Tissue 5‐hydroxytryptamine and urinary 5‐hydroxyindoleacetic acid after partial or total removal of the gastro‐intestinal tract in the ratThe Journal of Physiology, 1960
- Distribution of 5‐hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tractThe Journal of Physiology, 1953